Advanced Pancreatic Cancer Trial - NU 18I01 Another poster recently mentioned more data from the other Pancreatic Cancer trial in combination with Keytruda.
Well, this is from ClinicalTrials.Gov.
Terminated (The total accrual goal of 34 patients was not met. Stage 1 of the study did not meet the interim analysis criteria to move onto Stage 2 of the Simon 2 stage design.)
So, I find it somewhat peculiar that ONCY still have this trial listed in their pipeline, when the trial was terminated and went no further. It failed to meet the criteria to move into Phase II. Safe and well tolerated, but nothing else.
Still think this company is worth 8 billion..?